Neuren Pharmaceuticals Ltd
OTC:NURPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neuren Pharmaceuticals Ltd
OTC:NURPF
|
AU |
|
D
|
Diageo PLC
XBER:GUI
|
UK |
Wall St Price Targets
NURPF Price Targets Summary
Neuren Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for NURPF is 14.64 USD with a low forecast of 11.498 USD and a high forecast of 18.638 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NURPF's stock price target?
Price Target
14.64
USD
According to Wall Street analysts, the average 1-year price target for NURPF is 14.64 USD with a low forecast of 11.498 USD and a high forecast of 18.638 USD.
What is the Revenue forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 38%.
What is the Operating Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
132%
The compound annual growth rate for Operating Income over the next 4 years is 132%.
What is the Net Income forecast for Neuren Pharmaceuticals Ltd?
Projected CAGR
119%
The compound annual growth rate for Net Income over the next 4 years is 119%.
